Head-to-head · Cost-Efficiency Index
Clume Health vs Maximus
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Clume Health
Readers who want the dispensing pharmacies named up front and do not need the price broken out by molecule.
Visit Clume HealthMaximus
People who want compounded tirzepatide at a flat price across doses and are willing to prepay at least two months, or who want brand-name pens and tablets in the same account.
Visit MaximusThe verdict
Clume Health and Maximus tie on the Cost-Efficiency Index at 73/100, so neither wins outright on the numbers, so choose on fit. Clume Health: Readers who want the dispensing pharmacies named up front and do not need the price broken out by molecule. Maximus: People who want compounded tirzepatide at a flat price across doses and are willing to prepay at least two months, or who want brand-name pens and tablets in the same account.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Clume Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Clume Health | Maximus |
|---|---|---|
| Cost-Efficiency Index | 73/100 | 73/100 |
| Semaglutide / mo | $259/monthMonth-to-month (one Signature price covers semaglutide or tirzepatide, oral or injectable; $186/mo needs a 52-week plan) | Not offered |
| Tirzepatide / mo | $259/monthMonth-to-month (the same Signature price; $186/mo needs a 52-week plan) | $249.99/mo2-month plan, billed up front, compounded |
| Semaglutide / yr (modeled) | $3,108 | — |
| Tirzepatide / yr (modeled) | $3,108 | $2,988 |
| Coverage | All 50 states | 47 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #91 | #92 |
Clume Health
73/100Where the value is
- Names all four dispensing pharmacies with street addresses, phone numbers and websites, so a buyer can look up who actually compounds the prescription
- The price is published before the intake and covers the consultation, ongoing oversight, the medication and delivery
- One figure covers semaglutide, tirzepatide, oral and injectable, so switching molecule or route does not change the bill
The tradeoffs
- Both headline prices on the homepage match nothing on sale: "*$199/month" against real floors of $259 and $219, and "*$159/month" against $216 — and neither asterisk resolves to a footnote
- The cheaper monthly figures are commitments rather than rates: $186 a month requires a 52-week plan and $200 a month a 12-week one
Maximus
73/100Where the value is
- Its pricing FAQ lists every plan length: $249.99 a month on 2 months, $219.99 on 4, $199.99 on 6 and $149.99 on 12, with no separate first-month price
- One flat rate covers every dose tier, with no membership fee and free shipping
- Also offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro pens plus the Wegovy and Foundayo tablets
The tradeoffs
- There is no month-to-month tirzepatide plan: the shortest is two months, billed up front, and plans renew automatically at the same term
- No compounded semaglutide option
Regulatory note: the FDA issued a warning letter to Maximus Health, Inc. dba Maximus in June 2026. We still list and link to Maximus; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.